Gossamer Bio GOSS
NASDAQ GOSS
$10.05 +0.47 (+4.91%)
As of: Oct 21, 2026 · 2:55 PM EDT

Gossamer Bio (GOSS) Total Non-Current Liabilities (2018 - 2026)

Updated

Gossamer Bio (GOSS) recorded Total Non-Current Liabilities of $127.96 million in Q2 2026.

Analysis

Gossamer Bio (GOSS) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, Gossamer Bio reported Total Non-Current Liabilities of $295.01 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,137.36 Bn 1,105.95 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 617.62 Bn 536.15 Bn 17.26 Bn 105.50 Bn
3 AbbVie 501.17 Bn 474.28 Bn 12.70 Bn 106.45 Bn
4 Merck 368.13 Bn 322.51 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.23 Bn 234.92 Bn 12.86 Bn 33.91 Bn
7 Amgen 236.68 Bn 192.08 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 190.97 Bn 165.17 Bn 6.22 Bn 35.10 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn 97.04 Bn
10 Gossamer Bio 40.34 Mn -433.06 Mn - 127.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 127.96 Mn
Dec 31, 2025 295.01 Mn
Dec 31, 2018 358.77 Mn
API Access

Gossamer Bio Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GOSS&period=max&api_key=YOUR_API_KEY